Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
176,717,443
-
Total 13F shares
-
19,316,233
-
Share change
-
+3,606,630
-
Total reported value
-
$359,305,882
-
Price per share
-
$18.60
-
Number of holders
-
55
-
Value change
-
+$66,970,759
-
Number of buys
-
42
-
Number of sells
-
10
Institutional Holders of Wave Life Sciences Ltd. - COMMON STOCK (WVE) as of Q2 2017
As of 30 Jun 2017,
Wave Life Sciences Ltd. - COMMON STOCK (WVE) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,316,233 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, Redmile Group, LLC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Foresite Capital Management III, LLC, DEERFIELD MANAGEMENT CO, PERCEPTIVE ADVISORS LLC, New Leaf Venture Partners, L.L.C., BlackRock Inc., and EVENTIDE ASSET MANAGEMENT, LLC.
This page lists
55
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.